Shares of MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD – Get Free Report) fell 14.1% during mid-day trading on Thursday . The stock traded as low as $0.15 and last traded at $0.15. 3,256,342 shares were traded during trading, an increase of 2,328% from the average session volume of 134,123 shares. The stock had previously closed at $0.18.
MyMD Pharmaceuticals Stock Performance
The company’s 50 day moving average price is $0.27 and its 200-day moving average price is $0.75.
MyMD Pharmaceuticals Company Profile
MyMD Pharmaceuticals, Inc, a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the aging and age-related and autoimmune diseases, and chronic pain, anxiety, and sleep disorders. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system and its pro-inflammatory cytokines to prevent and treat autoimmune diseases and age-related illnesses, and a Phase 2 clinical trial for sarcopenia, multiple sclerosis, diabetes, inflammatory bowel diseases, and rheumatoid arthritis; inflammation related depression and anxiety; and COVID-19-associated depression.
Featured Stories
- Five stocks we like better than MyMD Pharmaceuticals
- Where Do I Find 52-Week Highs and Lows?
- Turbulence for Joby Shares: What’s Behind the Recent Dip?
- Financial Services Stocks Investing
- Why Carnival Could Be the Ultimate Non-Tech Growth Stock
- How to Calculate Options Profits
- Super Micro Computer Stock Clears New Path Higher on Saudi Orders
Receive News & Ratings for MyMD Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MyMD Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
